サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：小動物呼吸器疾患治療の世界市場：成長、将来展望、競合分析 (2022年～2030年)
市場調査レポート
商品コード
1184708

小動物呼吸器疾患治療の世界市場：成長、将来展望、競合分析 (2022年～2030年)

Small Animal Respiratory Diseases Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
小動物呼吸器疾患治療の世界市場：成長、将来展望、競合分析 (2022年～2030年)
出版日: 2022年08月23日
発行: Acute Market Reports
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の小動物呼吸器疾患治療市場を調査し、市場動向、競合情報、セグメント分析、新興動向、技術分析、競合情勢、および企業プロファイルなどの情報を提供しています。

目次

第1章 序文

  • レポート概要
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の小動物呼吸器疾患治療市場
  • 世界の小動物呼吸器疾患治療市場：疾患別（2021年）
  • 世界の小動物呼吸器疾患治療市場：薬剤クラス別（2021年）
  • 世界の小動物呼吸器疾患治療市場：地域別（2021年）
  • 魅力的な投資提案：地域別（2021年）

第3章 小動物呼吸器疾患治療市場：競合分析

  • 主要な小動物呼吸器疾患治療市場ベンダーの市場ポジショニング
  • 小動物呼吸器疾患治療市場ベンダーの採用戦略
  • 主要な業界戦略
  • 階層分析：2021年対2030年

第4章 小動物呼吸器疾患治療市場：マクロ分析と市場力学

  • イントロダクション
  • 世界の小動物呼吸器疾患治療市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因と抑制要因の影響分析
  • シーソー分析

第5章 小動物呼吸器疾患治療市場：疾患別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • アレルギー性肺炎
    • 犬インフルエンザ
    • 犬鼻ダニ
    • 肺線虫
    • 呼吸器系腫瘍形成
    • 肺炎
    • 鼻炎・副鼻腔炎
    • 扁桃炎
    • その他

第6章 小動物呼吸器疾患治療市場：薬剤クラス別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • 駆虫薬
    • 非ステロイド系抗炎症薬（NSAID）
    • コルチコステロイド
    • 抗生物質
    • 抗ヒスタミン剤
    • ホスホジエステラーゼ（PDE）阻害剤
    • 気管支拡張薬
    • 抗悪性腫瘍剤
    • その他

第7章 北米の小動物呼吸器疾患治療市場（2020年～2030年）

  • 市場概要
  • 小動物呼吸器疾患治療市場：疾患別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：薬剤クラス別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：地域別（2020年～2030年）
    • 北米

第8章 英国・欧州連合の小動物呼吸器疾患治療市場（2020年～2030年）

  • 市場概要
  • 小動物呼吸器疾患治療市場：疾患別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：薬剤クラス別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：地域別（2020年～2030年）
    • 英国・欧州連合

第9章 アジア太平洋の小動物呼吸器疾患治療市場（2020年～2030年）

  • 市場概要
  • 小動物呼吸器疾患治療市場：疾患別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：薬剤クラス別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：地域別（2020年～2030年）
    • アジア太平洋

第10章 ラテンアメリカの小動物呼吸器疾患治療市場（2020年～2030年）

  • 市場概要
  • 小動物呼吸器疾患治療市場：疾患別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：薬剤クラス別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：地域別（2020年～2030年）
    • ラテンアメリカ

第11章 中東・アフリカの小動物呼吸器疾患治療市場（2020年～2030年）

  • 市場概要
  • 小動物呼吸器疾患治療市場：疾患別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：薬剤クラス別（2020年～2030年）
  • 小動物呼吸器疾患治療市場：地域別（2020年～2030年）
    • 中東・アフリカ

第12章 企業プロファイル

  • Zoetis, Inc.
  • Merck Animal Health
  • Merial Inc.（Sanofi S.A）
  • Boehringer Ingelheim GmbH
  • Elanco Animal Health（Eli Lilly）
  • Bayer AG
  • Ceva Animal Health
  • Heska Corporation
  • Vetoquinol SA
  • Virbac Ltd.
  • Cipla Vet
図表

List of Tables

  • TABLE 1 Global Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 2 Global Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 3 North America Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 4 North America Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 5 U.S. Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 6 U.S. Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 7 Canada Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 8 Canada Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 9 Rest of North America Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 10 Rest of North America Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 11 UK and European Union Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 12 UK and European Union Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 13 UK Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 14 UK Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 15 Germany Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 16 Germany Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 17 Spain Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 18 Spain Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 19 Italy Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 20 Italy Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 21 France Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 22 France Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 23 Rest of Europe Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 24 Rest of Europe Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 25 Asia Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 26 Asia Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 27 China Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 28 China Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 29 Japan Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 30 Japan Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 31 India Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 32 India Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 33 Australia Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 34 Australia Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 35 South Korea Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 36 South Korea Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 37 Latin America Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 38 Latin America Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 39 Brazil Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 40 Brazil Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 41 Mexico Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 42 Mexico Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 43 Rest of Latin America Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 44 Rest of Latin America Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 45 Middle East and Africa Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 46 Middle East and Africa Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 47 GCC Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 48 GCC Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 49 Africa Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 50 Africa Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Small Animal Respiratory Diseases Treatment Market By Diseases, 2020-2030, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Small Animal Respiratory Diseases Treatment Market By Drug Class, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Small Animal Respiratory Diseases Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Small Animal Respiratory Diseases Treatment Market: Quality Assurance
  • FIG. 5 Global Small Animal Respiratory Diseases Treatment Market, By Diseases, 2021
  • FIG. 6 Global Small Animal Respiratory Diseases Treatment Market, By Drug Class, 2021
  • FIG. 7 Global Small Animal Respiratory Diseases Treatment Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Small Animal Respiratory Diseases Treatment Market, 2021
  • FIG. 9 Market Positioning of Key Small Animal Respiratory Diseases Treatment Market Players, 2021
  • FIG. 10 Global Small Animal Respiratory Diseases Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Small Animal Respiratory Diseases Treatment Market, By Diseases, 2021 Vs 2030, %
  • FIG. 12 Global Small Animal Respiratory Diseases Treatment Market, By Drug Class, 2021 Vs 2030, %
  • FIG. 13 U.S. Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 France Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 China Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 India Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Small Animal Respiratory Diseases Treatment Market (US$ Million), 2020 - 2030
目次
Product Code: 137343-08-22

This report on global small animal respiratory diseases treatment market studies various type of diseases, drug class and geography. According to veterinary medical experts, upper respiratory infections- also called canine infectious respiratory disease (CIRD) is mainly caused in spaces occupied or visited by many pets such as boarding houses, groomers, and parks. These kind of infections are also known commonly as "Kennel Cough" because of the honking, dry sound made by infected animals, URI in pets is complex to diagnose because it can be caused by both bacteria or viruses and in most cases multiple agents are involved. These infections are highly contagious especially when dogs or cats get together in high-density situations such as pet stores and animal shelters the sanitization is the most important factor.

For the purpose of this study, the various types of diseases considered are allergic pneumonitis, canine influenza, canine nasal mites, lung nematodes, neoplasia of respiratory system, pneumonia, rhinitis and sinusitis, tonsilitis, and others.

The market segmentation on the basis types of drug class comprises sub-segments such as anthelmintics, NSAIDs, corticosteroids, antibiotics, antihistamines, phosphodiesterase (PDE) inhibitors, bronchodilators, antineoplastic agents, and others.

The geographic segmentation of the global small animal respiratory diseases treatment market is performed for the regions North America, Europe, Asia-Pacific, Latin America and Middle East & Africa markets. The regions are also further sub-segmented on the basis of major countries.

The key players covered in small animal respiratory diseases treatment market are Zoetis, Inc., Merck Animal Health, Merial Inc. (Sanofi S.A), Boehringer Ingelheim GmbH, Elanco Animal Health (Eli Lilly), Bayer AG, Ceva Animal Health, Heska Corporation, Vetoquinol SA, Virbac Ltd., and Cipla Vet.

In May 2013, Small Animal CPD Meeting sponsored by Boehringer Ingelheim Vetmedica involved discussion with experts about the common symptoms observed in small animals such as coughing or dyspnoea with common disorders such as brachycephalic syndrome, laryngeal paralysis, tracheal collapse, and feline asthma syndrome.

According to market experts, allergic pneumonitis, canine influenza, rhinitis and sinusitis and tonsillitis were observed as the most common respiratory diseases observed in small animals. According to American Veterinary Medical Foundation, the first recognized U.S. outbreak of H3N2 canine influenza occurred in 2015, starting in Chicago and spreading to other Midwestern states. Since March 2015, outbreaks have occurred in a number of areas throughout the U.S. and thousands of dogs have been confirmed positive for the H3N2 virus. It was observed that prevalence of canine influenza was also observed in cats and the displayed signs of upper respiratory disease including discharge, congestion, malaise, lip smacking and excessive salivation. Rhinitis and sinusitis are considered as the most infrequent problems in small animals but with changes occurring in environment with presence of air pollution and sudden environmental change may lead to chronic nasal diseases. The breed predilections for rhinitis and sinusitis comprised short-nose flat-faced cats that are more prone to chronic inflammation of the nose and most of the times fungal rhinitis. In case of dogs it is mainly observed in dogs with a long head and nose and these dogs are more prone to Aspergillus infection and nasal tumors. According to a research paper published by Daniel L. Hamilos in ATS Journals, ambient mold spores are widely distributed in nature, and an estimated 3 to 10% of the world's animal population is allergic to molds. The research study also suggests that compelling epidemiologic links between mold (fungal) allergy and illnesses such as asthma and asthma with allergic rhinitis. Fungal allergy is more prevalent in areas of high ambient mold spore concentrations. Hence, market dynamics of small animals respiratory diseases treatment involved the developing pet keeping trend in urban population mostly involving small animals, rising air pollution and abrupt environmental changes are affecting respiratory health of small animals, and maintenance of unsanitary conditions around pets also affect their respiratory system.

According to Royal Veterinary College, in U.K per 1000 dogs 23.2 dogs suffers with Kennel cough, 9.5 dogs suffer with coughing, 6.7 dogs are diagnosed with upper respiratory tract infection (URTI), and 3.9 dogs suffer with brachycephalic airway obstruction syndrome (BAOS).

In 2021, it was observed that anthelmintics, corticosteroids and antibiotics accounted for more than 50% market share of the overall small animal respiratory diseases treatment market. According to market experts, most anthelmintics have wide safety margins, i.e., the dosage that can be given to an animal before adverse effects are induced is much higher than the dosage recommended for use. Thus, anthelmintics are prescribed very cautiously in small animals as the dose plays very critical role in the treatment of the diseases and anticipated side-effects. The most commonly used antibiotics in small animal respiratory diseases treatment are amoxicillin and cephalexin, sulfamethox, gentamicin, chloramphenicol, sulfadimethoxine, tetracycline, and doxycycline. The bacteria's growth and further multiplication is inhibited by bacteriostatic antibiotics. Glucocorticoids through several mechanisms project the anti-inflammatory and immunosuppressive actions in the body that helps to overcome respiratory diseases in small animals.

North America was observed as the largest market for small animal respiratory diseases treatment market due to factors such as rising air pollution, lack of sanitation related to pets in a few households, increasing urban trend of having dogs and cats as pets and rising awareness associated with the well-being of small animals. The European small animal respiratory diseases treatment market has displayed significant growth recently, albeit from a fairly low base compared to other regions. According to market experts, consumers in the region are more likely to own pets and provide them all the facilities as a family member. There is a noticeable inclination towards pet humanization, especially among young, urban and affluent consumers, and is expected to trade up to mid-priced or premium products. In 2015, Asia-Pacific was observed as the fastest growing small animal respiratory diseases treatment market due to key driving factors such as rising trend of keeping dogs and cats as pet in urban areas, increasing awareness in pet owners especially associated with several life-threatening diseases, and pet humanization trend is increasing rapidly in Asian countries.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Small Animal Respiratory Diseases Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Small Animal Respiratory Diseases Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Diseases

Allergic Pneumonitis

Canine Influenza

Canine Nasal Mites

Lung Nematodes

Neoplasia Of Respiratory System

Pneumonia

Rhinitis And Sinusitis

Tonsilitis

Other Respiratory Diseases

Drug Class

Anthelmintics

Non-steroidal anti-inflammatory drugs (NSAIDs)

Corticosteroids

Antibiotics

Antihistamines

Phosphodiesterase (PDE) inhibitors

Bronchodilators

Antineoplastic Agents

Others

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Small Animal Respiratory Diseases Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Small Animal Respiratory Diseases Treatment market?

Which is the largest regional market for Small Animal Respiratory Diseases Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Small Animal Respiratory Diseases Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Small Animal Respiratory Diseases Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Small Animal Respiratory Diseases Treatment Market
  • 2.2. Global Small Animal Respiratory Diseases Treatment Market, By Diseases, 2021 (US$ Million)
  • 2.3. Global Small Animal Respiratory Diseases Treatment Market, By Drug Class, 2021 (US$ Million)
  • 2.4. Global Small Animal Respiratory Diseases Treatment Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Small Animal Respiratory Diseases Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Small Animal Respiratory Diseases Treatment Market Vendors
  • 3.2. Strategies Adopted by Small Animal Respiratory Diseases Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Small Animal Respiratory Diseases Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Small Animal Respiratory Diseases Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Allergic Pneumonitis
    • 5.3.2. Canine Influenza
    • 5.3.3. Canine Nasal Mites
    • 5.3.4. Lung Nematodes
    • 5.3.5. Neoplasia Of Respiratory System
    • 5.3.6. Pneumonia
    • 5.3.7. Rhinitis And Sinusitis
    • 5.3.8. Tonsilitis
    • 5.3.9. Other Respiratory Diseases

6. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Anthelmintics
    • 6.3.2. Non-steroidal anti-inflammatory drugs (NSAIDs)
    • 6.3.3. Corticosteroids
    • 6.3.4. Antibiotics
    • 6.3.5. Antihistamines
    • 6.3.6. Phosphodiesterase (PDE) inhibitors
    • 6.3.7. Bronchodilators
    • 6.3.8. Antineoplastic Agents
    • 6.3.9. Others

7. North America Small Animal Respiratory Diseases Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
  • 7.3. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 7.4.Small Animal Respiratory Diseases Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 7.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 7.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 7.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)

8. UK and European Union Small Animal Respiratory Diseases Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
  • 8.3. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 8.4.Small Animal Respiratory Diseases Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 8.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 8.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 8.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 8.4.1.4.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 8.4.1.5.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 8.4.1.6.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)

9. Asia Pacific Small Animal Respiratory Diseases Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
  • 9.3. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 9.4.Small Animal Respiratory Diseases Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 9.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 9.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 9.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 9.4.1.4.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 9.4.1.5.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 9.4.1.6.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)

10. Latin America Small Animal Respiratory Diseases Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
  • 10.3. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 10.4.Small Animal Respiratory Diseases Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 10.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 10.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 10.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)

11. Middle East and Africa Small Animal Respiratory Diseases Treatment Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
  • 11.3. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
  • 11.4.Small Animal Respiratory Diseases Treatment Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 11.4.1.1.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 11.4.1.2.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Diseases, 2020-2030, USD (Million)
        • 11.4.1.3.1. Small Animal Respiratory Diseases Treatment Market: By Drug Class, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Zoetis, Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. Merck Animal Health
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Merial Inc. (Sanofi S.A)
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Boehringer Ingelheim GmbH
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Elanco Animal Health (Eli Lilly)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Bayer AG
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. Ceva Animal Health
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Heska Corporation
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Vetoquinol SA
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Virbac Ltd.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Cipla Vet
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives